期刊文献+

不同时间点给予丁丙诺啡透皮贴剂对全髋关节置换术后镇痛效果及不良反应的临床观察 被引量:5

Postoperative analgesic efficacy and safety of transdermal Buprenorphine dosed at different time points in total hip arthroplasty
在线阅读 下载PDF
导出
摘要 目的探究不同时间点给予丁丙诺啡透皮贴剂对全髋关节置换术(total hip arthroplasty,THA)后镇痛效果及不良反应的影响。方法将我院于2016年8月至2017年1月收治的90例须行THA的病人,随机分为术前48 h用药组(30例,术前48 h使用丁丙诺啡透皮贴剂)、术前24 h用药组(30例,术前24 h使用丁丙诺啡透皮贴剂)和术后即刻用药组(30例,术后立即使用丁丙诺啡透皮贴剂)。三组病人术后均使用病人自控静脉镇痛泵(patient controlled intravenous analgesia,PCIA),并记录术后4、12、24、48 h以及术后3、5 d的疼痛视觉模拟量表(visual analogue scale,VAS)评分、PCIA使用量、PCIA按压次数以及使用过程中出现的不良反应。结果术前48 h用药组有2例病人退出,最终88例病人完成本研究。经混合效应模型检验,本组病人的VAS评分、PCIA按压次数及PCIA剂量在不同时间点及不同组间均差异显著,且均随时间变化而变化。在术后4、12、24 h,术前48 h用药组的VAS评分、PCIA按压次数及PCIA使用剂量显著低于术前24 h用药组,术前24 h用药组的各项指标显著低于术后即刻用药组,差异均有统计学意义(P均<0.05);而在术后3、5 d,三组间的VAS评分比较,差异无统计学意义(P>0.05)。三组病人的不良反应发生情况相比,差异无统计学意义(χ~2=1.666,P=0.435)。结论 THA病人术前48 h使用丁丙诺啡透皮贴剂具有较理想的术后镇痛效果,且并不会增加不良反应的发生率,具有较好的应用前景。 Objective To explore the postoperative analgesic effect and complications of transdermalbuprenorphine dosed at different time points in patients undergoing total hip arthroplasty(THA).Methods Ninety patients receiving THA in our hospital were randomly divided into three groups:preoperative 48 htreatment group,preoperative 48 h treatment group and immediate treatment group,30 patients in each group,which were treated with transdermal buprenorphine respectively 48 h preoperatively,24 h preoperatively andimmediately after operation.Routine therapy and patient controlled intravenous analgesia(PCIA) were used inthree groups after operation.Visual analogue score(VAS),dosage and pressing times of PCIA at different timepoints(4 h,12 h,24 h,48 h,3 days and 5 days after operation) were recorded,while the adverse reactions werereported on a standard SAE form during the whole study.Results There were 2 cases backed out of thisproject in the preoperative 48 h treatment group,finally,88 patients completed the study.The results of themixed effects model test showed significant differences in VAS score,dosage of PCIA and pressing times ofPCIA among the three groups and the different time points.VAS score,dosage of PCIA and pressing times ofPCIA varied with time.VAS score,dosage of PCIA and pressing times of PCIA in preoperative 48 h treatmentgroup were the lowest in three groups at 4,12,24 h postoperatively,and which were the highest in theimmediate treatment group.The differences were statistically significant(P<0.05 for all).But there was nosignificant difference between two groups separately at 3rd and 5th day postoperatively.There was nosignificant difference in the occurrence of complications(χ~2=1.666,P=0.435).Conclusion Preferableanalgesic effect could be provided by dosing transdermal buprenorphine at 48 h preoperation,withoutincreasing the incidence of adverse reactions.
出处 《骨科》 CAS 2017年第3期227-232,共6页 ORTHOPAEDICS
基金 国家自然科学基金(81572200)
关键词 关节成形术 置换 丁丙诺啡 透皮贴剂 镇痛药 阿片类 Arthroplasty,replacement,hip Buprenorphine Transdermal patch Analgesics,opioid
  • 相关文献

参考文献17

二级参考文献215

共引文献525

同被引文献42

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部